Alpine Immune Sciences alpineimmunesciences.com

Alpine Immune Sciences uses proprietary variant immunoglobulin domain (vIgD) platform technology – designed to interact with multiple targets simultaneously in the immune synapse using a single molecule – to develop novel protein‐based immunotherapies. The company has also developed transmembrane immunomodulatory protein (TIP) technology, based on vIgD, for direct applications with engineered cellular therapies, potentially improving efficacy and persistence.

Alpine Immune Sciences uses proprietary variant immunoglobulin domain (vIgD) platform technology – designed to interact with multiple targets simultaneously in the immune synapse using a single molecule – to develop novel protein‐based immunoth...Show all

See All Exits Recent Exits

Phone: 206-788-4545

Fax:

201 Elliott Avenue West
Suite 230
Seattle, 98119
Washington, United States

Alpine Immune Sciences - Investments & Acquisitions

Show Real Data Alpine Immune Sciences Investments
See all Recent Investments
Date Company Round Amount Co-investors
2017-07-21Nivalis TherapeuticsMerger
See all 1 investments